CU6 2.70% $6.13 clarity pharmaceuticals ltd

CU6 - ASX Charts, page-330

  1. 6,805 Posts.
    lightbulb Created with Sketch. 1744
    @daveg - If this wasn’t the case for Clarity IMHO the current valuation is probably unjustified simply based on trial results. My guess is the valuation has more short term (transaction within 1 year) expectation built into it than pure valuation assigned to future revenues/ profits based on positive trials.

    AIMO.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.